Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized Standard Protocol for Severe Aplastic Anemia
NCT02203396Phase 2Completed
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Aug 2014
- Primary completion
- Sep 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit, cyclosporine, levamisole in aplastic anemia, sponsored by Institute of Hematology and Blood Diseases Hospital. Started Aug 2014; status: completed.
02
Drugs
antithymocyte globulin rabbitcyclosporinelevamisole
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT02203396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02203396.